In vitro activities of the ketolides ABT-773 and telithromycin and of three macrolides against genetically characterized isolates of Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis

被引:19
|
作者
Schmitz, FJ
Schwarz, S
Milatovic, D
Verhoef, J
Fluit, AC
机构
[1] Univ Dusseldorf, Inst Med Microbiol & Virol, D-40225 Dusseldorf, Germany
[2] Eijkman Winkler Inst Med Microbiol, Utrecht, Netherlands
[3] Bundesforschungsanstalt Landwirtschaft, Inst Tierzucht & Tierverhalten, Celle, Germany
关键词
D O I
10.1093/jac/dkf085
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:145 / 148
页数:4
相关论文
共 50 条
  • [31] Streptococcus pyogenes isolates with characterized macrolide resistance mechanisms in Spain:: in vitro activities of telithromycin and cethromycin
    Morosini, MI
    Cantón, R
    Loza, E
    del Campo, R
    Almaraz, F
    Baquero, F
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (01) : 50 - 55
  • [32] In vitro bactericidal activity of ABT-773 and amoxicillin against erythromycin-susceptible and -resistant strains of Streptococcus pyogenes
    Pendland, SL
    Neuhauser, MM
    Prause, JL
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (04) : 671 - 674
  • [33] Genotypic characterization of macrolide-resistant strains of Streptococcus pneumoniae isolated in Quebec, Canada, and in vitro activity of ABT-773 and telithromycin
    Weiss, K
    Guilbault, C
    Cortes, L
    Restieri, C
    Low, DE
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (03) : 403 - 406
  • [34] Comparison of in vitro Activities of Tigecycline with Other Antimicrobial Agents against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Two University Hospitals in Istanbul, Turkey
    Gonullu, Nevriye
    Catal, Fadimana
    Kucukbasmaci, Omer
    Ozdemir, Sinem
    Torun, Muzeyyen Mamal
    Berkiten, Rahmiye
    [J]. CHEMOTHERAPY, 2009, 55 (03) : 161 - 167
  • [35] Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents:: a prospective US study
    Thornsberry, C
    Ogilvie, PT
    Holley, HP
    Sahm, DF
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (11) : 2612 - 2623
  • [36] In vitro activity of the novel ketolide HMR 3647 and comparative oral antibiotics against Canadian respiratory tract isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
    Hoban, DJ
    Zhanel, GG
    Karlowsky, JA
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1999, 35 (01) : 37 - 44
  • [37] In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms
    Morosini, MI
    Cantón, R
    Loza, E
    Negri, MC
    Galán, JC
    Almaraz, F
    Baquero, F
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (09) : 2427 - 2431
  • [38] In Vitro Antimicrobial Activity of Cefditoren against Streptococcus pneumoniae and Haemophilus influenzae Clinical Isolates
    Kim, Nam Joong
    Kim, Sung Hye
    Kim, Mi Young
    Jun, Jae Bum
    Park, Su Jin
    Kwak, Yee Gyung
    Jeong, Jin-Yong
    Choi, Sang-Ho
    Woo, Jun Hee
    Ryu, Jiso
    Kim, Yang Soo
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 26 : S83 - S83
  • [39] Antimicrobial activity and in vitro susceptibility test development for cefditoren against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus species
    Johnson, DM
    Biedenbach, DJ
    Beach, ML
    Pfaller, MA
    Jones, RN
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2000, 37 (02) : 99 - 105
  • [40] In vitro susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis:: a European multicenter study during 2000-2001
    Jones, ME
    Blosser-Middleton, RS
    Critchley, IA
    Karlowsky, JA
    Thornsberry, C
    Sahm, DF
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2003, 9 (07) : 590 - 599